GlassScriptPhysician profile
Sarah Graham
NPI 1568773075
$791.18
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $147 · 2021: $16.23.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $198.74 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $103.60 | 2019-2020 | |
| Pfizer INC. | $86.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.08 | 2019-2020 | |
| Amgen INC. | $51.65 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.84 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $29.44 | 2019-2020 | |
| Glaxosmithkline, LLC. | $28.48 | 2019 | |
| Horizon Therapeutics Plc | $27.71 | 2020 | |
| Medtronic USA, INC. | $19.56 | 2019 | |
| Hologic Sales and Service, LLC | $19.46 | 2019 | |
| Shire North American Group INC | $18.69 | 2019 | |
| Allergan, INC. | $17.10 | 2019 | |
| Irhythm Technologies, INC. | $16.23 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.